C4X Discovery ( C4XD ) has teamed with AI firm GTN to maximise drug - specific chemistry modeling and to create promising candidates in the area of neurodegeneration . GTN uses deep - learning and quantum physics for drug discovery by simulating , identifying and searching for molecules concealed from established technologies . However , it faces problems with AI ’s over - simplification when it comes to representing molecules in medicinal chemistry . C4XD will use the precise measurements from its conformational analysis platform , Conformetrix , to give GTN the molecular descriptors needed for its in silico identification capabilities .
C4X Discovery (C4XD) has teamed with AI firm GTN to maximise shape-based chemistry insights and to create drug candidates in the area of neurodegeneration. GTN uses deep-learning and quantum physics for drug discovery by simulating, filtering and searching for molecules concealed from established technologies. However, it faces challenges with AI’s over-simplification when it comes to representing molecules in medicinal chemistry. C4XD will use the precise measurements from its conformational analysis platform, Conformetrix, to give GTN the molecular descriptors needed for its in silico identification platform.